165 related articles for article (PubMed ID: 11993719)
1. Attenuation of oxalate-induced nephrotoxicity by eicosapentaenoate-lipoate (EPA-LA) derivative in experimental rat model.
Lenin M; Thiagarajan A; Nagaraj M; Varalakshmi P
Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):265-70. PubMed ID: 11993719
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effect of triterpenes on urinary risk factors of stone formation in pyridoxine deficient hyperoxaluric rats.
Vidya L; Lenin M; Varalakshmi P
Phytother Res; 2002 Sep; 16(6):514-8. PubMed ID: 12237806
[TBL] [Abstract][Full Text] [Related]
3. Oxidative renal injury and lipoprotein oxidation in hypercholesterolemic atherogenesis: Role of eicosapentaenoate-lipoate (EPA-LA) derivative.
Kumar SA; Sudhahar V; Varalakshmi P
Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):25-31. PubMed ID: 16737804
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic role of phycocyanin: a study of oxalate mediated renal cell injury.
Farooq SM; Asokan D; Kalaiselvi P; Sakthivel R; Varalakshmi P
Chem Biol Interact; 2004 Aug; 149(1):1-7. PubMed ID: 15294440
[TBL] [Abstract][Full Text] [Related]
5. Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate.
Subha K; Varalakshmi P
Biochem Mol Biol Int; 1993 Feb; 29(2):271-80. PubMed ID: 7684293
[TBL] [Abstract][Full Text] [Related]
6. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of serum lipid abnormalities and cardiac oxidative stress by eicosapentaenoate-lipoate (EPA-LA) derivative in experimental hypercholesterolemia.
Kumar SA; Sudhahar V; Varalakshmi P
Clin Chim Acta; 2005 May; 355(1-2):197-204. PubMed ID: 15820496
[TBL] [Abstract][Full Text] [Related]
8. Mitigation of free radical toxicity in hyperoxaluric condition by a novel derivative eicosapentaenoate-lipoate.
Lenin M; Latha LM; Nagaraj M; Varalakshmi P
Hum Exp Toxicol; 2002 Mar; 21(3):153-8. PubMed ID: 12102541
[TBL] [Abstract][Full Text] [Related]
9. Counteraction of oxalate induced nitrosative stress by supplementation of l-arginine, a potent antilithic agent.
Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
Clin Chim Acta; 2005 Apr; 354(1-2):159-66. PubMed ID: 15748613
[TBL] [Abstract][Full Text] [Related]
10. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
[TBL] [Abstract][Full Text] [Related]
11. Protective role of eicosapentaenoate-lipoate (EPA-LA) derivative in combating oxidative hepatocellular injury in hypercholesterolemic atherogenesis.
Kumar SA; Sudhahar V; Varalakshmi P
Atherosclerosis; 2006 Nov; 189(1):115-22. PubMed ID: 16458314
[TBL] [Abstract][Full Text] [Related]
12. Renal peroxidative changes mediated by oxalate: the protective role of fucoidan.
Veena CK; Josephine A; Preetha SP; Varalakshmi P; Sundarapandiyan R
Life Sci; 2006 Oct; 79(19):1789-95. PubMed ID: 16820173
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
Thamilselvan S; Menon M
BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
[TBL] [Abstract][Full Text] [Related]
14. Role of lipoic acid in reducing the oxidative stress induced by cyclosporine A.
Amudha G; Josephine A; Varalakshmi P
Clin Chim Acta; 2006 Oct; 372(1-2):134-9. PubMed ID: 16716285
[TBL] [Abstract][Full Text] [Related]
15. Lipoic acid in combination with a chelator ameliorates lead-induced peroxidative damages in rat kidney.
Sivaprasad R; Nagaraj M; Varalakshmi P
Arch Toxicol; 2002 Aug; 76(8):437-41. PubMed ID: 12185410
[TBL] [Abstract][Full Text] [Related]
16. Antiurolithic effect of lupeol and lupeol linoleate in experimental hyperoxaluria.
Sudhahar V; Veena CK; Varalakshmi P
J Nat Prod; 2008 Sep; 71(9):1509-12. PubMed ID: 18717586
[TBL] [Abstract][Full Text] [Related]
17. Effect of DL alpha-lipoic acid on some carbohydrate metabolising enzymes in stone forming rats.
Jayanthi S; Jayanthi G; Varalakshmi P
Biochem Int; 1991 Sep; 25(1):123-36. PubMed ID: 1663349
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of lipoic acid in combination with dimercaptosuccinic acid against lead-induced renal tubular defects and on isolated brush-border enzyme activities.
Sivaprasad TR; Malarkodi SP; Varalakshmi P
Chem Biol Interact; 2004 Apr; 147(3):259-71. PubMed ID: 15135082
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of DL-alpha-lipoic acid on cyclosporine A induced renal alterations.
Amudha G; Josephine A; Mythili Y; Sundarapandiyan R; Varalakshmi P
Eur J Pharmacol; 2007 Oct; 571(2-3):209-14. PubMed ID: 17619014
[TBL] [Abstract][Full Text] [Related]
20. Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria.
Vidya L; Varalakshmi P
Fitoterapia; 2000 Sep; 71(5):535-43. PubMed ID: 11449502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
